España F - Search Results

1

Euglobulin clot lysis induced by tissue type plasminogen activator in subjects with increased levels and different isoforms of lipoprotein (a).

Aznar J, Estellés A, Bretó M, España F. Aznar J, et al. Among authors: espana f. Thromb Res. 1993 Dec 1;72(5):459-65. doi: 10.1016/0049-3848(93)90247-l. Thromb Res. 1993. PMID: 8303689 No abstract available.

2

Euglobulin clot lysis induced by tissue-type plasminogen activator is reduced in subjects with increased levels of lipoprotein (a).

Aznar J, Estellés A, Bretó M, España F, Alós T. Aznar J, et al. Among authors: espana f. Thromb Res. 1992 Jun 1;66(5):569-82. doi: 10.1016/0049-3848(92)90311-w. Thromb Res. 1992. PMID: 1387993

3

Activated protein C: alpha 1-antitrypsin (APC: alpha 1 AT) complex as a marker for in vitro diagnosis of prethrombotic states.

España F, Gilabert J, Vicente V, Estellés A, Vazquez L, Hendl S, Aznar J. España F, et al. Thromb Res. 1992 Jun 1;66(5):499-508. doi: 10.1016/0049-3848(92)90304-s. Thromb Res. 1992. PMID: 1523606

4

Functionally active protein C inhibitor/plasminogen activator inhibitor-3 (PCI/PAI-3) is secreted in seminal vesicles, occurs at high concentrations in human seminal plasma and complexes with prostate-specific antigen.

España F, Gilabert J, Estellés A, Romeu A, Aznar J, Cabo A. España F, et al. Thromb Res. 1991 Nov 1;64(3):309-20. doi: 10.1016/0049-3848(91)90002-e. Thromb Res. 1991. PMID: 1725227

5

Determination of total, free and complexed protein S in plasma by ELISA, and comparison with a standard electroimmunoassay.

España F, Hendl S, Aznar J, Gilabert J, Estellés A. España F, et al. Thromb Res. 1991 Jun 15;62(6):615-24. doi: 10.1016/0049-3848(91)90366-5. Thromb Res. 1991. PMID: 1833853

6

Interaction of plasma kallikrein with protein C inhibitor in purified mixtures and in plasma.

España F, Estelles A, Griffin JH, Aznar J. España F, et al. Thromb Haemost. 1991 Jan 23;65(1):46-51. Thromb Haemost. 1991. PMID: 1850876

7

Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia.

Estellés A, Gilabert J, España F, Aznar J, Galbis M. Estellés A, et al. Among authors: espana f. Am J Obstet Gynecol. 1991 Jul;165(1):138-42. doi: 10.1016/0002-9378(91)90242-j. Am J Obstet Gynecol. 1991. PMID: 1906680

8

Plasminogen activator inhibitors type 1 and type 2 and plasminogen activators in amniotic fluid during pregnancy.

Estellés A, Gilabert J, Andrés C, España F, Aznar J. Estellés A, et al. Among authors: espana f. Thromb Haemost. 1990 Oct 22;64(2):281-5. Thromb Haemost. 1990. PMID: 2125378

9

Contribution of platelets to increased plasminogen activator inhibitor type 1 in severe preeclampsia.

Gilabert J, Estellés A, Aznar J, España F, Andrés C, Santos T, Vallés J. Gilabert J, et al. Among authors: espana f. Thromb Haemost. 1990 Jun 28;63(3):361-6. Thromb Haemost. 1990. PMID: 2144918

10

Clinical and haemostatic parameters in the HELLP syndrome: relevance of plasminogen activator inhibitors.

Gilabert J, Estellés A, Ridocci F, España F, Aznar J, Galbis M. Gilabert J, et al. Among authors: espana f. Gynecol Obstet Invest. 1990;30(2):81-6. doi: 10.1159/000293222. Gynecol Obstet Invest. 1990. PMID: 2147163

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results